About Novacyt Group

Novacyt Group, an international specialist in cancer and infectious diseases, has diversified sales from diagnostic products used in LBC, oncology, microbiology, haematology and serology testing.

We support a large global customer base which includes hospitals to large corporates. Our proprietary technology platform NOVAPREP® is a unique next generation liquid based cytology solution focused on cancer management.

novaprep

Cytology Products

NovaPrep® is a next generation liquid based cytology solution, utilised in the diagnosis of cervical cancer.

lab21

Clinical Laboratory

Lab 21 provide specialised and routine clinical laboratory testing services to clinicians, healthcare providers and patients.

microgen

Microbiology

Microgen Bioproducts develop, manufacture and distribute high quality diagnostic products for clinical and food laboratories.

plasmatec

Haematology & Serology Products

Plasmatec manufactures and markets in vitro diagnostic tests across more than 70 countries worldwide.

biotec

Haematology & Serology Products

Biotec is a leading manufacturer and supplier of diagnostic reagents, test kits and blood grouping reagents.

primer-design

Real Time PCR

The best custom qPCR assay development service in the World

Novacyt Group History

Novacyt noticeably evolved since the acquisition of Lab 21 in June 2014.

timeline-novacyt2

2005
Inception of Lab 21 (Microgen, Biotec, Plasmatec and Lab 21)

2006
Inception of Novacyt SA

2008
Initial commercial launch of NOVAPREP®

2012
Listing of Novacyt on Alternext Paris

2014
Acquisition of Lab 21

2016
Acquisition of Primer Design

Quality Policy

Within the Novacyt Group, we are committed to Quality as a fundamental part of all its business activities and strives to meet and exceed external and internal customer expectations. As a learning organisation we will continuously drive innovation, improvements and excellence for all our products and services whilst meeting all regulatory requirements for the markets we serve.

To support this, we have established this Quality Policy and have the following Quality Objectives:

To implement and maintain a Quality Management System that complies with the requirements laid down in the IVD Directive (98/79/EC), EN ISO 13485:2012 and other regulations as required to support business activities

To monitor and measure the performance of both the products we sell, and the systems and processes we operate to identify and implement continuous improvements

To ensure that the importance of Quality is communicated to all employees throughout the business through regular information updates, and that employees are trained and supported to deliver good products and services

To involve all employees in owning and improving the Quality Management System to the benefit of customers, employees and other stakeholder groups

To place Quality as a fundamental cornerstone of annual business strategic planning

This Quality Policy will be reviewed annually for continuing suitability.